| Name | Title | Contact Details |
|---|---|---|
Tracy Dowling |
General Counsel | Profile |
Tracy Dowling |
General Counsel, Head of Business Development | Profile |
Fubao Wang |
Senior Vice President and Head of Regulatory Affairs | Profile |
Libra Therapeutics is focused on developing novel disease-modifying therapeutics that can restore the cellular balance disrupted in neurodegenerative diseases.
febit is a Lexington, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ribon Therapeutics is a biotech company focused on developing first-in-class therapeutics targeting mono(ADP-ribosyl)ating PARPs for cancer.
Biomea Fusion, Inc. was formed in 2017 by a small group of biotech executives. We are dedicated to developing innovative medicines for patients. It is our goal to design and clinically develop patient friendly therapies with higher efficacy than the current standard of care.
Engineering next‑generation, brain‑penetrant cancer therapies.